DoW Melanoma Research Program Idea Award
Defense Health Agency Contracting Activity - DHACA · Military Medical Research and Development (12.420)
Posted 21 May 2026 · 13 days left
In plain terms
The US Defense Health Agency funds innovative, high-risk melanoma research projects through its Fiscal Year 2026 Idea Award programme, open to any type of US-based organisation or individual. Applicants must submit a pre-application by 14 October 2026 and receive an invitation before submitting a full application.
A generated summary of the donor's text; the original wording is below.
Summary
Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Idea Award supports innovative, exploratory, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding.
Distinctive Features:
• Preliminary data are discouraged.
• After submitting the required pre-application, investigators must receive an invitation to submit a full application.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Who can apply
- NGO / civil society
- Community-based organisation
- Government body
- Academic or research institution
- Private company
- Social enterprise or cooperative
- Individual
- UN or intergovernmental agency
- Other applicant type
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"